Catabasis Pharmaceuticals, Inc. Approves Election of Kenneth Bate as Class II Director from Class III Director

Catabasis Pharmaceuticals, Inc. announced that upon his election as a Class II director of the company at the Annual Meeting of Stockholders held on June 7, 2017, Kenneth Bate, who previously served as a Class III director of the company, resigned as Class III director.